Close Menu

NEW YORK – Quanterix reported after the close of the market on Wednesday that its third quarter revenues rose 41 percent year over year, driven by an 80 percent increase in product revenues.

For the three months ended Sept. 30, the Billerica, Massachusetts-based company posted Q3 revenues of $14.9 million, up from $10.6 million in Q3 2018, beating the consensus Wall Street estimate of $12.6 million. Excluding $1.3 million recognized in Q3 2018 connected to the termination of a license agreement, revenue was up 62 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.